Primary pulmonary mucoepidermoid carcinoma: an analysis of 21 cases

Table 2 Pathology and survival information

Number	Grade	Stage	T	N	EGFR IHC	EGFR mutation	Recurrence metastasis	Survival status	OS/month/month	PFS/month/month
1	Low	Ia	1a	0	50%++	N/A	-	Alive	29	29
2	Low	Ia	1a	0	0	-	-	Alive	76	76
3	Low	Ia	1a	0	0	-	-	Alive	77	77
4	Low	Ia	1b	0	0	-	-	Alive	62	62
5	Low	Ia	1b	0	0	-	-	Alive	5	5
6	Low	Ib	2a	0	30%+	-	-	Alive	22	22
7	Low	Ib	2a	0	0	-	-	Alive	46	46
8	Low	Ib	2a	0	0	-	Recurrence	Dead	41	40
9	Low	Ib	2a	0	90%+	-	-	Alive	66	66
10	Low	Ib	2a	0	0	-	-	Alive	67	67
11	Low	Ib	2a	0	0	-	-	Alive	67	67
12	Low	IIa	2a	1	20%+	-	-	Alive	29	29
13	Low	IIb	3	0	0	-	-	Alive	5	5
14	Low	IIb	3	0	0	-	-	Alive	54	54
15	Low	IIIb	4	2	90%++	-	-	Perioperative dead	-	-
16	Low	-	3	x	0	N/A	-	Alive	74	74
17	Low	-	1b	x	0	-	-	Alive	25	25
18	High	Ia	1a	0	0	-	-	Alive	47	47
19	High	IIb	2b	1	100%+	-	Contralateral lung metastasis	Dead	65	63
20	High	IIIa	2a	2	0	-	Recurrence	Dead	31	30
21	High	IIIa	2a	2	0	-	Liver metastasis	Dead	23	15

EGFR epidermal growth factor receptor, IHC immunohistochemistry, N/A not available, OS overall survival, PFS Progression-free survival, TNM tumor-node-metastasis.

ISSN: 1477-7819